In today’s Pharma Pulse, HHS issues guidance for manufacturer-direct drug discounts, while clinical data warns of significant ...
For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...
Lastly, Insilico Medicine has inked a $120 million deal with Qilu Pharmaceuticals. The company will be using Insilico’s ...
In the final part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, explains how federated ...
Morris & Dickson's acquisition of Prodigy Health strengthens its specialty pharmaceutical distribution and expands access to ...
Discover how access barriers evolve across the biopharma brand lifecycle, from launch to loss of exclusivity, and how to ...
In today’s Pharma Pulse, extreme weather tests the resilience of community pharmacies, while CMS proposes a near-flat 0.09% update for Medicare Advantage and Part D payments in 2027.
In the second part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, describes how AI-driven ...
How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike. The status quo ...
The FDA ImportShield Program centralizes import review, increasing processing speed by 66% and volume capacity by 33%, while ...
In today’s Pharma Pulse, over 200 health groups denounce childhood vaccine schedule cuts, GSK acquires RAPT Therapeutics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results